Skip to main content
BioCentury on BioBusiness
Feature Story

Cover Story: Politics, Policy & Law: Speed trials

How the Ebola outbreak sparked the fastest vaccine development efforts ever

By Steve Usdin, Washington Editor

The 2014 West Africa Ebola outbreak is stimulating the fastest vaccine development efforts ever attempted, demonstrating the power of an emerging model that combines the expertise, capabilities and resources of experienced pharma companies, government biomedical research agencies, philanthropies and non-governmental organizations.

Difficult challenges must be overcome before one or more vaccines are ready for widespread use, so it is too early to declare victory. But it is already clear that the model will have to be expanded or modified if it is to become a template for addressing the many known infectious disease threats, or creating the capacity to rapidly respond to new ones.

Read Article
  • THE DISTILLERY brings you this week's most essential scientific findings in therapeutics, distilled by Innovations editors from a weekly review of more than 400 papers in 41 of the highest-impact journals in the fields of biotechnology, the life sciences and chemistry. The Distillery goes beyond the abstracts to explain the commercial relevance of featured research, including licensing status and companies working in the field, where applicable.

    This week in therapeutics includes important research findings on targets and compounds, grouped first by disease class and then alphabetically by indication.

    This week in techniques includes findings about research tools, disease models and manufacturing processes that have the potential to enable or improve all stages of drug discovery and development.

Subscribe Now
Free Trial

Management Updates

There were no items published for this section in the most recent issue. Click more >> to read previously published items.